BioCentury | Sep 1, 2014
Finance

Exiting Covagen

...largest for a preclinical company over the past five years. One of the biotech's investors, Seroba Kernel Life Sciences Ltd....
BioCentury | May 26, 2014
Finance

Europe's Iceberg 2014: Premier League teams

...10/2 (series C) BB Biotech Ventures; Novartis Venture Funds; Fountain Healthcare Partners; Roche Venture Fund; Seroba Kernel Life Sciences Ltd....
BioCentury | May 6, 2013
Financial News

Opsona completes venture financing

...$43 million) Investors: BB Biotech Ventures; Novartis Venture Funds; Fountain Healthcare Partners; Roche Venture Fund; Seroba Kernel Life Sciences Ltd....
BioCentury | Dec 6, 2010
Company News

Xention board of directors update

...Xention Ltd. , Cambridge, U.K. Business: Cardiovascular, Autoimmune, Genitourinary Appointed: Graham Fagg, partner at Seroba Kernel Life Sciences Ltd. and...
BioCentury | Dec 6, 2010
Financial News

Xention completes venture financing

...Cardiovascular, Autoimmune, Genitourinary Date completed: 11/23/10 Type: Venture financing Raised: £8 million ($12.8 million) Investors: Seroba Kernel Life Sciences Ltd....
BioCentury | Dec 6, 2010
Company News

Covagen board of directors update

...Covagen AG , Zurich, Switzerland Business: Inflammation, Cancer, Autoimmune Appointed: Jonathan Hepple, partner at Seroba Kernel Life Sciences Ltd. WIR Staff...
Items per page:
1 - 6 of 6
BioCentury | Sep 1, 2014
Finance

Exiting Covagen

...largest for a preclinical company over the past five years. One of the biotech's investors, Seroba Kernel Life Sciences Ltd....
BioCentury | May 26, 2014
Finance

Europe's Iceberg 2014: Premier League teams

...10/2 (series C) BB Biotech Ventures; Novartis Venture Funds; Fountain Healthcare Partners; Roche Venture Fund; Seroba Kernel Life Sciences Ltd....
BioCentury | May 6, 2013
Financial News

Opsona completes venture financing

...$43 million) Investors: BB Biotech Ventures; Novartis Venture Funds; Fountain Healthcare Partners; Roche Venture Fund; Seroba Kernel Life Sciences Ltd....
BioCentury | Dec 6, 2010
Company News

Xention board of directors update

...Xention Ltd. , Cambridge, U.K. Business: Cardiovascular, Autoimmune, Genitourinary Appointed: Graham Fagg, partner at Seroba Kernel Life Sciences Ltd. and...
BioCentury | Dec 6, 2010
Financial News

Xention completes venture financing

...Cardiovascular, Autoimmune, Genitourinary Date completed: 11/23/10 Type: Venture financing Raised: £8 million ($12.8 million) Investors: Seroba Kernel Life Sciences Ltd....
BioCentury | Dec 6, 2010
Company News

Covagen board of directors update

...Covagen AG , Zurich, Switzerland Business: Inflammation, Cancer, Autoimmune Appointed: Jonathan Hepple, partner at Seroba Kernel Life Sciences Ltd. WIR Staff...
Items per page:
1 - 6 of 6